Celine Leung, DO
Neurology with Special Qualifications in Child Neurology · Hackensack, NJNPI 1477970630
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations.
Across 73 payments — averaging $20.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- SK Life Science, Inc.$303
- AbbVie$220
- UCB, Inc.$134
- Jazz Pharmaceuticals Inc.$129
- Supernus Pharmaceuticals, Inc.$112
- Amgen$99
- plus $471 from 16 others
What the payments were for
- Food & beverage$1,469100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| SK Life Science, Inc. | 12 | $303 |
| AbbVie | 8 | $220 |
| UCB, Inc. | 8 | $134 |
| Jazz Pharmaceuticals Inc. | 8 | $129 |
| Supernus Pharmaceuticals, Inc. | 6 | $112 |
| Amgen | 1 | $99 |
| Pfizer | 5 | $86 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $57 |
| Otter Pharmaceuticals, LLC | 3 | $46 |
| Neurelis, Inc. | 3 | $45 |
| Greenwich Biosciences, Inc. | 3 | $39 |
| Vertical Pharmaceuticals, LLC | 1 | $35 |
| Aucta Pharmaceuticals, Inc. | 2 | $21 |
| Sunovion Pharmaceuticals Inc. | 1 | $20 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $19 |
| Amneal Pharmaceuticals LLC | 1 | $18 |
| Tris Pharma Inc | 1 | $16 |
| Impel Pharmaceuticals Inc. | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Aquestive Therapeutics, Inc. | 1 | $13 |
| Lilly USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QULIPTA$124
How this compares
$1,469 in reported general payments places this provider in the 70th percentile of 69 neurology with special qualifications in child neurology providers in New Jersey.
See all neurology with special qualifications in child neurology providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology with special qualifications in child neurology in Hackensack
- Juliann PaolicchiHackensack$80K
- Sara RubensteinHackensack$7K
- Michael KatzHackensack$2K
- Rolando SousaHackensack$2K
- Yelena RoshchinaHackensack$313
- Trevor DesouzaMorristown$14K
- Rao PasupuletiHamilton$11K
- Aliza AlterLivingston$9K
- Carlos LastraNew Brunswick$5K
- Jacqueline RomeroMarlboro$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.